Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 27 February, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Cerebra Integrated Technologies Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 27, 2025, 2:54 pm

Market Cap 66.0 Cr.
Current Price 5.45
High / Low 15.9/5.15
Stock P/E
Book Value 14.9
Dividend Yield0.00 %
ROCE13.4 %
ROE15.0 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Cerebra Integrated Technologies Ltd

Competitors of Cerebra Integrated Technologies Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Computer Point Ltd 14.9 Cr. 4.96 11.6/3.70 11.10.00 %0.03 %0.03 % 10.0
ACI Infocom Ltd 24.4 Cr. 2.21 3.67/1.78 1.480.00 %1.07 %0.53 % 1.00
TVS Electronics Ltd 573 Cr. 306 490/235 50.50.33 %0.73 %0.08 % 10.0
Panache Digilife Ltd 407 Cr. 268 346/64.454.0 40.80.00 %12.8 %13.2 % 10.0
HCL Infosystems Ltd 430 Cr. 13.1 23.6/12.5 8.530.00 %28.0 %% 2.00
Industry Average1,009.50 Cr314.0743.5366.360.33%15.14%13.83%6.50

All Competitor Stocks of Cerebra Integrated Technologies Ltd

Quarterly Result

MetricDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales 2420216370773029131371812
Expenses 15201650556725251115132632
Operating Profit 915131510542-1-7-8-20
OPM % 37%3%23%21%21%12%17%14%16%-11%-97%-44%-167%
Other Income 0000050-0000-5-8
Interest 3112122223222
Depreciation 0000000000000
Profit before tax 6-14121312320-5-8-15-30
Tax % 28%-138%17%15%15%70%22%22%23%63%0%-10%0%
Net Profit 4-2310114210-2-8-16-30
EPS in Rs 0.35-0.100.210.691.090.290.180.100.03-0.14-0.69-1.33-2.46

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for Cerebra Integrated Technologies Ltd based on the most recent figures (Dec 2023) and their trends compared to the previous period:

  • For Sales, as of Dec 2023, the value is ₹12.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹18.00 Cr. (Sep 2023) to ₹12.00 Cr., marking a decrease of ₹6.00 Cr..
  • For Expenses, as of Dec 2023, the value is ₹32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹26.00 Cr. (Sep 2023) to ₹32.00 Cr., marking an increase of ₹6.00 Cr..
  • For Operating Profit, as of Dec 2023, the value is ₹-20.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹-8.00 Cr. (Sep 2023) to ₹-20.00 Cr., marking a decrease of ₹12.00 Cr..
  • For OPM %, as of Dec 2023, the value is -167.00%. The value appears to be declining and may need further review. It has decreased from -44.00% (Sep 2023) to -167.00%, marking a decrease of 123.00%.
  • For Other Income, as of Dec 2023, the value is ₹-8.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹-5.00 Cr. (Sep 2023) to ₹-8.00 Cr., marking a decrease of ₹3.00 Cr..
  • For Interest, as of Dec 2023, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2023) which recorded ₹2.00 Cr..
  • For Depreciation, as of Dec 2023, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2023) which recorded ₹0.00 Cr..
  • For Profit before tax, as of Dec 2023, the value is ₹-30.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹-15.00 Cr. (Sep 2023) to ₹-30.00 Cr., marking a decrease of ₹15.00 Cr..
  • For Tax %, as of Dec 2023, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -10.00% (Sep 2023) to 0.00%, marking an increase of 10.00%.
  • For Net Profit, as of Dec 2023, the value is ₹-30.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹-16.00 Cr. (Sep 2023) to ₹-30.00 Cr., marking a decrease of ₹14.00 Cr..
  • For EPS in Rs, as of Dec 2023, the value is ₹-2.46. The value appears to be declining and may need further review. It has decreased from ₹-1.33 (Sep 2023) to ₹-2.46, marking a decrease of ₹1.13.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MetricSep 2012Sep 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales 163231130267238250314385182702318651
Expenses 157224128261236237272343149611887670
Operating Profit 673721342423394210-19
OPM % 4%3%2%3%1%5%13%11%18%12%18%11%-37%
Other Income 1110312-18-150500
Interest 11133124346108
Depreciation 1101100000000
Profit before tax 56232134220144400-27
Tax % 28%6%12%11%17%7%17%71%15%68%32%-1,475%
Net Profit 3622212356121273-26
EPS in Rs 0.621.110.300.220.171.042.690.360.940.142.260.21-2.13
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)0.00%0.00%500.00%191.67%-82.86%100.00%-91.67%2600.00%-88.89%
Change in YoY Net Profit Growth (%)0.00%0.00%500.00%-308.33%-274.52%182.86%-191.67%2691.67%-2688.89%

Cerebra Integrated Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:-9%
5 Years:-34%
3 Years:-11%
TTM:-4%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:54%
Stock Price CAGR
10 Years:-10%
5 Years:-32%
3 Years:-58%
1 Year:-31%
Return on Equity
10 Years:3%
5 Years:1%
3 Years:-1%
Last Year:-15%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 3:49 pm

MonthSep 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 48488496108120121121121112112112112
Reserves 434549526613614717317114614810069
Borrowings 574019334131832413940
Other Liabilities 357959141551041931417313598101100
Total Liabilities 131178231181332363466448384425399352321
Fixed Assets 9876699910101099
CWIP 000030068733333
Investments 00010140000000
Other Assets 122170224174323340456371301412386340309
Total Assets 131178231181332363466448384425399352321

Below is a detailed analysis of the balance sheet data for Cerebra Integrated Technologies Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹112.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹112.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹69.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹100.00 Cr. (Mar 2024) to ₹69.00 Cr., marking a decrease of ₹31.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹40.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹39.00 Cr. (Mar 2024) to ₹40.00 Cr., marking an increase of ₹1.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹100.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹101.00 Cr. (Mar 2024) to ₹100.00 Cr., marking a decrease of ₹1.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹321.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹352.00 Cr. (Mar 2024) to ₹321.00 Cr., marking a decrease of ₹31.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹9.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹3.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹309.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹340.00 Cr. (Mar 2024) to ₹309.00 Cr., marking a decrease of ₹31.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹321.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹352.00 Cr. (Mar 2024) to ₹321.00 Cr., marking a decrease of ₹31.00 Cr..

Notably, the Reserves (₹69.00 Cr.) exceed the Borrowings (₹40.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthSep 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +-0-1-6133-30-20-10-5-17-22
Cash from Investing Activity +-4-2-01-3-1719-52-9-0-13
Cash from Financing Activity +-0-069-9-15101-642-3
Net Cash Flow-5-4635-14-1-61-21-14-02

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2012Sep 2013
Free Cash Flow-4.00-33.00-17.0010.0039.0038.0020.00-9.0010.00-31.006.002.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthSep 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days9531013496315233321499889299596882
Inventory Days243926442253421248269237
Days Payable392087216247134193302290186310430
Cash Conversion Cycle81140878471121133231811161556689
Working Capital Days74149887793141155283712188544657
ROCE %7%3%4%3%8%20%18%12%3%15%3%-13%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters7.10%7.10%5.05%5.05%5.05%2.79%0.23%0.23%0.23%0.23%0.84%0.84%
FIIs0.02%0.31%0.19%7.98%0.73%0.08%0.01%0.01%0.01%0.01%0.01%0.01%
DIIs17.41%17.41%17.41%9.82%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Government0.00%0.00%0.00%0.00%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%
Public75.47%75.18%77.35%77.16%94.17%97.08%99.71%99.70%99.70%99.70%99.09%99.09%
No. of Shareholders16,85618,91123,83227,76030,50140,50140,74340,56239,99039,69639,53838,668

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -4.322.452.450.100.94
Diluted EPS (Rs.) -4.322.312.310.100.94
Cash EPS (Rs.) -4.280.262.490.131.03
Book Value[Excl.RevalReserv]/Share (Rs.) 18.7523.0622.8424.6224.82
Book Value[Incl.RevalReserv]/Share (Rs.) 18.7523.0622.8424.6224.82
Revenue From Operations / Share (Rs.) 4.647.7020.635.7715.02
PBDIT / Share (Rs.) -3.230.914.210.722.94
PBIT / Share (Rs.) -3.270.884.170.682.91
PBT / Share (Rs.) -4.970.013.610.321.19
Net Profit / Share (Rs.) -4.320.222.450.101.01
NP After MI And SOA / Share (Rs.) -4.320.222.450.130.94
PBDIT Margin (%) -69.6811.9420.4012.5419.59
PBIT Margin (%) -70.5011.4520.2111.9219.40
PBT Margin (%) -106.980.1717.515.597.90
Net Profit Margin (%) -92.972.9111.861.766.70
NP After MI And SOA Margin (%) -92.962.9211.862.426.28
Return on Networth / Equity (%) -22.780.9610.630.573.88
Return on Capital Employeed (%) -17.443.8118.222.7811.69
Return On Assets (%) -13.710.636.450.442.55
Total Debt / Equity (X) 0.180.150.120.050.03
Asset Turnover Ratio (%) 0.130.200.560.170.24
Current Ratio (X) 1.371.641.522.512.03
Quick Ratio (X) 1.151.311.392.201.95
Inventory Turnover Ratio (X) 1.241.807.050.652.52
Interest Coverage Ratio (X) -6.071.087.541.9811.54
Interest Coverage Ratio (Post Tax) (X) -4.921.285.391.2810.72
Enterprise Value (Cr.) 107.12117.47911.09640.14213.70
EV / Net Operating Revenue (X) 2.061.363.949.151.17
EV / EBITDA (X) -2.9611.4119.3272.975.99
MarketCap / Net Operating Revenue (X) 1.370.933.828.921.19
Price / BV (X) 0.330.313.422.130.73
Price / Net Operating Revenue (X) 1.370.933.828.931.19
EarningsYield -0.670.030.030.000.05

After reviewing the key financial ratios for Cerebra Integrated Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is -4.32. This value is below the healthy minimum of 5. It has decreased from 2.45 (Mar 23) to -4.32, marking a decrease of 6.77.
  • For Diluted EPS (Rs.), as of Mar 24, the value is -4.32. This value is below the healthy minimum of 5. It has decreased from 2.31 (Mar 23) to -4.32, marking a decrease of 6.63.
  • For Cash EPS (Rs.), as of Mar 24, the value is -4.28. This value is below the healthy minimum of 3. It has decreased from 0.26 (Mar 23) to -4.28, marking a decrease of 4.54.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 18.75. It has decreased from 23.06 (Mar 23) to 18.75, marking a decrease of 4.31.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 18.75. It has decreased from 23.06 (Mar 23) to 18.75, marking a decrease of 4.31.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 4.64. It has decreased from 7.70 (Mar 23) to 4.64, marking a decrease of 3.06.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is -3.23. This value is below the healthy minimum of 2. It has decreased from 0.91 (Mar 23) to -3.23, marking a decrease of 4.14.
  • For PBIT / Share (Rs.), as of Mar 24, the value is -3.27. This value is below the healthy minimum of 0. It has decreased from 0.88 (Mar 23) to -3.27, marking a decrease of 4.15.
  • For PBT / Share (Rs.), as of Mar 24, the value is -4.97. This value is below the healthy minimum of 0. It has decreased from 0.01 (Mar 23) to -4.97, marking a decrease of 4.98.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is -4.32. This value is below the healthy minimum of 2. It has decreased from 0.22 (Mar 23) to -4.32, marking a decrease of 4.54.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -4.32. This value is below the healthy minimum of 2. It has decreased from 0.22 (Mar 23) to -4.32, marking a decrease of 4.54.
  • For PBDIT Margin (%), as of Mar 24, the value is -69.68. This value is below the healthy minimum of 10. It has decreased from 11.94 (Mar 23) to -69.68, marking a decrease of 81.62.
  • For PBIT Margin (%), as of Mar 24, the value is -70.50. This value is below the healthy minimum of 10. It has decreased from 11.45 (Mar 23) to -70.50, marking a decrease of 81.95.
  • For PBT Margin (%), as of Mar 24, the value is -106.98. This value is below the healthy minimum of 10. It has decreased from 0.17 (Mar 23) to -106.98, marking a decrease of 107.15.
  • For Net Profit Margin (%), as of Mar 24, the value is -92.97. This value is below the healthy minimum of 5. It has decreased from 2.91 (Mar 23) to -92.97, marking a decrease of 95.88.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is -92.96. This value is below the healthy minimum of 8. It has decreased from 2.92 (Mar 23) to -92.96, marking a decrease of 95.88.
  • For Return on Networth / Equity (%), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 15. It has decreased from 0.96 (Mar 23) to -22.78, marking a decrease of 23.74.
  • For Return on Capital Employeed (%), as of Mar 24, the value is -17.44. This value is below the healthy minimum of 10. It has decreased from 3.81 (Mar 23) to -17.44, marking a decrease of 21.25.
  • For Return On Assets (%), as of Mar 24, the value is -13.71. This value is below the healthy minimum of 5. It has decreased from 0.63 (Mar 23) to -13.71, marking a decrease of 14.34.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.18. This value is within the healthy range. It has increased from 0.15 (Mar 23) to 0.18, marking an increase of 0.03.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.13. It has decreased from 0.20 (Mar 23) to 0.13, marking a decrease of 0.07.
  • For Current Ratio (X), as of Mar 24, the value is 1.37. This value is below the healthy minimum of 1.5. It has decreased from 1.64 (Mar 23) to 1.37, marking a decrease of 0.27.
  • For Quick Ratio (X), as of Mar 24, the value is 1.15. This value is within the healthy range. It has decreased from 1.31 (Mar 23) to 1.15, marking a decrease of 0.16.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.24. This value is below the healthy minimum of 4. It has decreased from 1.80 (Mar 23) to 1.24, marking a decrease of 0.56.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is -6.07. This value is below the healthy minimum of 3. It has decreased from 1.08 (Mar 23) to -6.07, marking a decrease of 7.15.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -4.92. This value is below the healthy minimum of 3. It has decreased from 1.28 (Mar 23) to -4.92, marking a decrease of 6.20.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 107.12. It has decreased from 117.47 (Mar 23) to 107.12, marking a decrease of 10.35.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.06. This value is within the healthy range. It has increased from 1.36 (Mar 23) to 2.06, marking an increase of 0.70.
  • For EV / EBITDA (X), as of Mar 24, the value is -2.96. This value is below the healthy minimum of 5. It has decreased from 11.41 (Mar 23) to -2.96, marking a decrease of 14.37.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.37. This value is within the healthy range. It has increased from 0.93 (Mar 23) to 1.37, marking an increase of 0.44.
  • For Price / BV (X), as of Mar 24, the value is 0.33. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 23) to 0.33, marking an increase of 0.02.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.37. This value is within the healthy range. It has increased from 0.93 (Mar 23) to 1.37, marking an increase of 0.44.
  • For EarningsYield, as of Mar 24, the value is -0.67. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to -0.67, marking a decrease of 0.70.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Cerebra Integrated Technologies Ltd as of February 27, 2025 is: ₹27.36

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 27, 2025, Cerebra Integrated Technologies Ltd is Undervalued by 402.02% compared to the current share price 5.45

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Intrinsic Value of Cerebra Integrated Technologies Ltd as of February 27, 2025 is: 20.66

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 27, 2025, Cerebra Integrated Technologies Ltd is Undervalued by 279.08% compared to the current share price ₹5.45

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Last 5 Year EPS CAGR: -24.48%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (103.46 cr) compared to borrowings (20.31 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (199.85 cr) and profit (9.54 cr) over the years.
  1. The stock has a low average ROCE of 6.92%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 263.42, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 263.75, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cerebra Integrated Technologies Ltd:
    1. Net Profit Margin: -92.97%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: -17.44% (Industry Average ROCE: 15.14%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: -22.78% (Industry Average ROE: 13.83%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): -4.92
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.15
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 0 (Industry average Stock P/E: 43.53)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.18
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Cerebra Integrated Technologies Ltd. is a Public Limited Listed company incorporated on 31/12/1993 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1993PLC015091 and registration number is 015091. Currently Company is involved in the business activities of Manufacture of bare printed circuit boards, loading of components onto printed circuit boards; manufacture of interface cards (e.g. sound, video, controllers, network, modems). Company's Total Operating Revenue is Rs. 51.98 Cr. and Equity Capital is Rs. 111.99 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
IT Networking Equipment#S-5, Off 3rd Cross, 1 Stage, Pennya Industrial Area, Bengaluru Karnataka 560058investors@cerebracomputers.com
http://www.cerebracomputers.com
Management
NamePosition Held
Mr. V RanganathanManaging Director
Mr. P VishwamurthyWholeTime Director & CFO

FAQ

What is the latest intrinsic value of Cerebra Integrated Technologies Ltd?

Let's break down Cerebra Integrated Technologies Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 27 February 2025:

  • Calculated Fair Value: ₹27.36
  • Current Market Price: ₹5.45
  • Variance: 402.02% higher

This suggests Cerebra Integrated Technologies Ltd is currently undervalued by 402.02%. For context:

  • Market Cap: 66.0 Cr.
  • 52-Week Range: 15.9/5.15
  • Reserves (Sep 2024): 69 Cr
  • Liabilities: 321 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of Cerebra Integrated Technologies Ltd?

The Market Cap of Cerebra Integrated Technologies Ltd is 66.0 Cr..

What is the current Stock Price of Cerebra Integrated Technologies Ltd as on 27 February 2025?

The current stock price of Cerebra Integrated Technologies Ltd as on 27 February 2025 is ₹5.45.

What is the High / Low of Cerebra Integrated Technologies Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Cerebra Integrated Technologies Ltd stocks is 15.9/5.15.

What is the Stock P/E of Cerebra Integrated Technologies Ltd?

The Stock P/E of Cerebra Integrated Technologies Ltd is .

What is the Book Value of Cerebra Integrated Technologies Ltd?

The Book Value of Cerebra Integrated Technologies Ltd is 14.9.

What is the Dividend Yield of Cerebra Integrated Technologies Ltd?

The Dividend Yield of Cerebra Integrated Technologies Ltd is 0.00 %.

What is the ROCE of Cerebra Integrated Technologies Ltd?

The ROCE of Cerebra Integrated Technologies Ltd is 13.4 %.

What is the ROE of Cerebra Integrated Technologies Ltd?

The ROE of Cerebra Integrated Technologies Ltd is 15.0 %.

What is the Face Value of Cerebra Integrated Technologies Ltd?

The Face Value of Cerebra Integrated Technologies Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Cerebra Integrated Technologies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE